Nasdaq · Common stock
Crescent Biopharma (CBIO)
$12.76 −$0.06 (−0.47%)
- Day’s range
- $12.50–$13.27
- Volume
- 210,636
CBIO price history
CBIO closed at $12.76 on Oct. 26, 2026. Over the past year, its daily close ranged from $8.94 on Feb. 13, 2026 to $26.98 on April 22, 2026.
Data table: CBIO daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $12.76 |
| Oct. 23, 2026 | $12.82 |
| Oct. 22, 2026 | $13.14 |
| Oct. 21, 2026 | $13.17 |
| Oct. 20, 2026 | $13.07 |
| Oct. 19, 2026 | $12.36 |
| Oct. 16, 2026 | $11.84 |
| Oct. 15, 2026 | $12.48 |
| Oct. 14, 2026 | $12.58 |
| Oct. 13, 2026 | $12.91 |
| Oct. 12, 2026 | $14.46 |
| Oct. 9, 2026 | $14.91 |
| Oct. 8, 2026 | $14.12 |
| Oct. 7, 2026 | $13.49 |
| Oct. 6, 2026 | $13.57 |
| Oct. 5, 2026 | $13.94 |
| Oct. 2, 2026 | $14.32 |
| Oct. 1, 2026 | $14.26 |
| Sept. 30, 2026 | $14.59 |
| Sept. 29, 2026 | $14.76 |
| Sept. 28, 2026 | $14.53 |
| Sept. 25, 2026 | $13.99 |
| Sept. 24, 2026 | $14.24 |
| Sept. 23, 2026 | $14.19 |
| Sept. 22, 2026 | $16.44 |
| Sept. 21, 2026 | $16.25 |
| Sept. 18, 2026 | $16.89 |
| Sept. 17, 2026 | $16.77 |
| Sept. 16, 2026 | $17.18 |
| Sept. 15, 2026 | $18.80 |
| Sept. 14, 2026 | $19.68 |
| Sept. 11, 2026 | $19.41 |
| Sept. 10, 2026 | $19.46 |
| Sept. 9, 2026 | $19.99 |
| Sept. 8, 2026 | $20.46 |
| Sept. 4, 2026 | $20.88 |
| Sept. 3, 2026 | $20.40 |
| Sept. 2, 2026 | $18.54 |
| Sept. 1, 2026 | $17.93 |
| Aug. 31, 2026 | $16.60 |
| Aug. 28, 2026 | $17.75 |
| Aug. 27, 2026 | $17.76 |
| Aug. 26, 2026 | $18.02 |
| Aug. 25, 2026 | $17.00 |
| Aug. 24, 2026 | $16.97 |
| Aug. 21, 2026 | $17.15 |
| Aug. 20, 2026 | $16.23 |
| Aug. 19, 2026 | $17.32 |
| Aug. 18, 2026 | $16.69 |
| Aug. 17, 2026 | $17.48 |
| Aug. 14, 2026 | $17.14 |
| Aug. 13, 2026 | $16.63 |
| Aug. 12, 2026 | $16.43 |
| Aug. 11, 2026 | $16.69 |
| Aug. 10, 2026 | $17.33 |
| Aug. 7, 2026 | $16.84 |
| Aug. 6, 2026 | $16.43 |
| Aug. 5, 2026 | $15.77 |
| Aug. 4, 2026 | $16.38 |
| Aug. 3, 2026 | $14.87 |
| July 31, 2026 | $14.47 |
| July 30, 2026 | $15.02 |
| July 29, 2026 | $14.77 |
| July 28, 2026 | $16.44 |
| July 27, 2026 | $16.93 |
| July 24, 2026 | $16.30 |
| July 23, 2026 | $17.03 |
| July 22, 2026 | $15.83 |
| July 21, 2026 | $16.64 |
| July 20, 2026 | $15.05 |
| July 17, 2026 | $14.75 |
| July 16, 2026 | $15.11 |
| July 15, 2026 | $15.67 |
| July 14, 2026 | $15.31 |
| July 13, 2026 | $15.69 |
| July 10, 2026 | $17.34 |
| July 9, 2026 | $16.76 |
| July 8, 2026 | $16.81 |
| July 7, 2026 | $17.03 |
| July 6, 2026 | $16.96 |
| July 2, 2026 | $17.09 |
| July 1, 2026 | $17.08 |
| June 30, 2026 | $18.00 |
| June 29, 2026 | $18.00 |
| June 26, 2026 | $18.56 |
| June 25, 2026 | $16.99 |
| June 24, 2026 | $17.36 |
| June 23, 2026 | $17.50 |
| June 22, 2026 | $17.57 |
| June 18, 2026 | $17.69 |
| June 17, 2026 | $18.21 |
| June 16, 2026 | $17.95 |
| June 15, 2026 | $18.19 |
| June 12, 2026 | $17.92 |
| June 11, 2026 | $18.34 |
| June 10, 2026 | $17.57 |
| June 9, 2026 | $18.00 |
| June 8, 2026 | $17.28 |
| June 5, 2026 | $18.00 |
| June 4, 2026 | $18.45 |
| June 3, 2026 | $17.98 |
| June 2, 2026 | $17.01 |
| June 1, 2026 | $19.72 |
| May 29, 2026 | $20.65 |
| May 28, 2026 | $21.47 |
| May 27, 2026 | $20.79 |
| May 26, 2026 | $20.35 |
| May 22, 2026 | $20.74 |
| May 21, 2026 | $20.23 |
| May 20, 2026 | $18.91 |
| May 19, 2026 | $18.48 |
| May 18, 2026 | $18.55 |
| May 15, 2026 | $19.97 |
| May 14, 2026 | $21.23 |
| May 13, 2026 | $19.61 |
| May 12, 2026 | $18.46 |
| May 11, 2026 | $18.52 |
| May 8, 2026 | $18.76 |
| May 7, 2026 | $18.00 |
| May 6, 2026 | $18.06 |
| May 5, 2026 | $18.08 |
| May 4, 2026 | $17.92 |
| May 1, 2026 | $18.07 |
| April 30, 2026 | $22.37 |
| April 29, 2026 | $20.94 |
| April 28, 2026 | $23.96 |
| April 27, 2026 | $25.15 |
| April 24, 2026 | $24.80 |
| April 23, 2026 | $25.70 |
| April 22, 2026 | $26.98 |
| April 21, 2026 | $24.57 |
| April 20, 2026 | $21.69 |
| April 17, 2026 | $21.28 |
| April 16, 2026 | $19.45 |
| April 15, 2026 | $19.95 |
| April 14, 2026 | $19.52 |
| April 13, 2026 | $17.99 |
| April 10, 2026 | $18.17 |
| April 9, 2026 | $19.10 |
| April 8, 2026 | $18.32 |
| April 7, 2026 | $19.21 |
| April 6, 2026 | $19.38 |
| April 2, 2026 | $19.40 |
| April 1, 2026 | $19.32 |
| March 31, 2026 | $18.37 |
| March 30, 2026 | $16.62 |
| March 27, 2026 | $15.16 |
| March 26, 2026 | $13.50 |
| March 25, 2026 | $11.78 |
| March 24, 2026 | $10.44 |
| March 23, 2026 | $11.04 |
| March 20, 2026 | $10.90 |
| March 19, 2026 | $10.62 |
| March 18, 2026 | $10.35 |
| March 17, 2026 | $11.10 |
| March 16, 2026 | $11.58 |
| March 13, 2026 | $11.18 |
| March 12, 2026 | $11.56 |
| March 11, 2026 | $11.88 |
| March 10, 2026 | $12.55 |
| March 9, 2026 | $12.02 |
| March 6, 2026 | $12.07 |
| March 5, 2026 | $11.33 |
| March 4, 2026 | $11.49 |
| March 3, 2026 | $11.19 |
| March 2, 2026 | $11.20 |
| Feb. 27, 2026 | $12.09 |
| Feb. 26, 2026 | $12.35 |
| Feb. 25, 2026 | $12.49 |
| Feb. 24, 2026 | $12.65 |
| Feb. 23, 2026 | $11.47 |
| Feb. 20, 2026 | $11.65 |
| Feb. 19, 2026 | $11.74 |
| Feb. 18, 2026 | $9.72 |
| Feb. 17, 2026 | $9.33 |
| Feb. 13, 2026 | $8.94 |
| Feb. 12, 2026 | $9.23 |
| Feb. 11, 2026 | $9.45 |
| Feb. 10, 2026 | $9.45 |
| Feb. 9, 2026 | $9.45 |
| Feb. 6, 2026 | $9.51 |
| Feb. 5, 2026 | $9.41 |
| Feb. 4, 2026 | $9.71 |
| Feb. 3, 2026 | $9.54 |
| Feb. 2, 2026 | $9.82 |
| Jan. 30, 2026 | $9.59 |
| Jan. 29, 2026 | $10.15 |
| Jan. 28, 2026 | $10.73 |
| Jan. 27, 2026 | $11.27 |
| Jan. 26, 2026 | $11.75 |
| Jan. 23, 2026 | $12.80 |
| Jan. 22, 2026 | $13.63 |
| Jan. 21, 2026 | $13.72 |
| Jan. 20, 2026 | $13.98 |
| Jan. 16, 2026 | $13.51 |
| Jan. 15, 2026 | $12.50 |
| Jan. 14, 2026 | $12.63 |
| Jan. 13, 2026 | $11.05 |
| Jan. 12, 2026 | $10.98 |
| Jan. 9, 2026 | $10.79 |
| Jan. 8, 2026 | $10.97 |
| Jan. 7, 2026 | $10.94 |
| Jan. 6, 2026 | $11.07 |
| Jan. 5, 2026 | $11.11 |
| Jan. 2, 2026 | $11.08 |
| Dec. 31, 2025 | $11.86 |
| Dec. 30, 2025 | $11.60 |
| Dec. 29, 2025 | $12.08 |
| Dec. 26, 2025 | $12.35 |
| Dec. 24, 2025 | $12.37 |
| Dec. 23, 2025 | $12.12 |
| Dec. 22, 2025 | $12.45 |
| Dec. 19, 2025 | $11.85 |
| Dec. 18, 2025 | $12.22 |
| Dec. 17, 2025 | $12.49 |
| Dec. 16, 2025 | $12.92 |
| Dec. 15, 2025 | $13.21 |
| Dec. 12, 2025 | $14.09 |
| Dec. 11, 2025 | $15.31 |
| Dec. 10, 2025 | $14.49 |
| Dec. 9, 2025 | $13.97 |
| Dec. 8, 2025 | $13.17 |
| Dec. 5, 2025 | $13.07 |
| Dec. 4, 2025 | $12.99 |
| Dec. 3, 2025 | $13.41 |
| Dec. 2, 2025 | $13.09 |
| Dec. 1, 2025 | $14.27 |
| Nov. 28, 2025 | $15.05 |
| Nov. 26, 2025 | $15.08 |
| Nov. 25, 2025 | $14.00 |
| Nov. 24, 2025 | $14.05 |
| Nov. 21, 2025 | $13.06 |
| Nov. 20, 2025 | $13.08 |
| Nov. 19, 2025 | $13.03 |
| Nov. 18, 2025 | $13.00 |
| Nov. 17, 2025 | $13.07 |
| Nov. 14, 2025 | $13.02 |
| Nov. 13, 2025 | $12.98 |
| Nov. 12, 2025 | $13.05 |
| Nov. 11, 2025 | $13.25 |
| Nov. 10, 2025 | $13.11 |
| Nov. 7, 2025 | $13.13 |
| Nov. 6, 2025 | $13.10 |
| Nov. 5, 2025 | $12.43 |
| Nov. 4, 2025 | $12.44 |
| Nov. 3, 2025 | $12.35 |
| Oct. 31, 2025 | $12.75 |
| Oct. 30, 2025 | $12.51 |
| Oct. 29, 2025 | $12.50 |
| Oct. 28, 2025 | $12.50 |
| Oct. 27, 2025 | $13.00 |
Key figures
- 52-week range
- $8.94–$26.98Low Feb. 13, 2026; high April 22, 2026
- Average daily volume
- 352,976Past 3 months
- Market value
- $474.0M
- Dividend yield
- —
- From 52-week high
- −52.71%
Price change
- 1 month
- −8.79%
- 3 months
- −21.72%
- Year to date
- +7.59%
- 1 year
- +0.55%
$1,000 a year ago
$1,000 put into CBIO at the close on Oct. 24, 2025 would be worth $1,006.
Price only, dividends not included.
What Wall Street says about CBIO
In the past 90 days, Wall Street firms published 4 rating or price-target actions on CBIO: 1 upgrade and 3 reiterated ratings.
| Action | Rating | |||
|---|---|---|---|---|
| HC Wainwright & Co. | Reiterates | Buy | $36 | |
| HC Wainwright & Co. | Upgrade | Neutral to Buy | $36 | |
| Wedbush | Reiterates | Outperform | $27 | |
| Wedbush | Reiterates | Outperform | $27 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Crescent Biopharma, Inc. Common Stock
Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent's pipeline product CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. The company focuses on advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.
- Headquarters
- Waltham, Mass.
- Employees
- 44
- Listed
- June 16, 2025
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about CBIO is on the site yet.